Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2019-06-25 Director's Dealing
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by company insiders, such as directors or major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions or changes in ownership status by company directors and executives.
2019-06-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (HLB Co., Ltd.) and its special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in control.
2019-06-25 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for HLB Life Science Co., Ltd. for the 21st fiscal year (2018). It contains detailed financial statements, management discussion and analysis, and corporate governance information. Although it is labeled as a 'Correction Report' (정정신고), it is a full-scale annual filing that includes the complete financial data and disclosures required for an annual report. Therefore, it is classified as a 10-K equivalent. FY 2018
2019-06-11 Korean
[기재정정]분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HLB Life Science Co., Ltd. for the period ending March 31, 2019. It contains detailed financial statements, management discussion, and corporate governance information. Although it is labeled as a 'Correction Report' (정정신고), it is a comprehensive financial filing that includes the full quarterly report content, not just an announcement of a report. Therefore, it is classified as an Interim/Quarterly Report. Q1 2019
2019-06-11 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding (a lawsuit for damages) and its subsequent resolution (withdrawal of the lawsuit). It uses standard Korean regulatory filing terminology for 'Legal Proceedings' (소송등의판결ㆍ결정). Since it details a specific legal case, its outcome, and the court involved, it fits the 'Legal Proceedings Report' category.
2019-06-05 Korean
증권발행결과(자율공시)(제8회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the 'Issuance Results' of a convertible bond (CB) by HLB Life Science. It details the specific financial instrument (8th series convertible bond), the issuance amount (60 billion KRW), and the payment date. This falls under the category of company fundraising and financing activities, specifically a capital/financing update.
2019-05-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.